☆ 4.2 Article

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis Data from Six Clinical and Phase I Safety Studies

CLINICAL DRUG INVESTIGATION (2010)

Related references

Note: Only part of the references are listed.
Review Ophthalmology

Acute bacterial conjunctivitis

Gunnar Hovding

ACTA OPHTHALMOLOGICA (2008)

Add to Collection
Review Ophthalmology

Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma

Christophe Baudouin

ACTA OPHTHALMOLOGICA (2008)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.